• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三叶草技术治疗复杂三尖瓣反流的长期结果(最长 14 年)。

Long-term results (up to 14 years) of the clover technique for the treatment of complex tricuspid valve regurgitation.

机构信息

Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.

Department of Anesthesia and Intensive Care, IRCCS San Raffaele Hospital, Milan, Italy.

出版信息

Eur J Cardiothorac Surg. 2017 Jul 1;52(1):125-130. doi: 10.1093/ejcts/ezx027.

DOI:10.1093/ejcts/ezx027
PMID:28329369
Abstract

OBJECTIVES

To report the long-term results of the clover technique for the treatment of complex forms of tricuspid regurgitation (TR).

METHODS

Ninety-six consecutive patients (mean age 60 ± 16.4, left ventricular ejection fraction 58 ± 8.8%) with severe or moderately-severe TR due to important leaflets prolapse/flail (81 patients), tethering (13 patients) or mixed (2 patients) lesions underwent clover repair combined with annuloplasty. The aetiology of TR was degenerative in 74 cases (77.1%), post-traumatic in 9 (9.4%) and secondary to dilated cardiomyopathy in 13 (13.5%). All patients but 3 (96.8%) underwent ring (59 patients, 61.5%) or suture (34 patients, 35.4%) annuloplasty. Concomitant procedures (mainly mitral surgery) were performed in 82 patients (85.4%).

RESULTS

Hospital mortality was 7.2%. At hospital discharge 92 (95.8%) patients had no or mild TR. Follow-up was 98% complete (median 9 years, interquartile range 5.1; 10.9). At 12 years the overall survival was 71.6 ± 7.22% and the cumulative incidence function of cardiac death with non-cardiac death as competing risk 16 ± 4.1% [95% confidence interval (95% CI) 9.5-25.7]. At 12 years the cumulative incidence function of TR ≥ 3+ and TR ≥ 2+ with death as competing risk were 1.2 ± 1.2% (95% CI 0.1-5.8) and 28 ± 7.7% (95% CI 14.3-43.5), respectively. Preoperative left ventricular ejection fraction (hazard ratio 0.9, CI 0.9-1, P  = 0.05) and previous cardiac surgery (hazard ratio 2.7, 95% CI 1-7.1, P  = 0.03) were predictors of recurrent TR ≥ 2+ at univariable but not at multivariable analysis.

CONCLUSIONS

Complex forms of TR due to severe prolapse or tethering of the leaflets can be effectively treated with the clover technique with very satisfactory long-term results and extremely low recurrence of severe TR.

摘要

目的

报告三尖瓣反流(TR)复杂形式的三叶草技术治疗的长期结果。

方法

96 例连续患者(平均年龄 60±16.4,左心室射血分数 58±8.8%)因重要瓣叶脱垂/连枷(81 例)、牵张(13 例)或混合(2 例)病变而出现严重或中度严重 TR,接受三叶草修复联合瓣环成形术。TR 的病因在 74 例(77.1%)中为退行性,9 例(9.4%)为创伤后,13 例(13.5%)为扩张型心肌病。除 3 例(96.8%)患者(96.8%)接受环(59 例,61.5%)或缝线(34 例,35.4%)瓣环成形术外,所有患者均接受环(59 例,61.5%)或缝线(34 例,35.4%)瓣环成形术。82 例(85.4%)患者同时进行了其他手术(主要为二尖瓣手术)。

结果

住院死亡率为 7.2%。出院时 92 例(95.8%)患者无或轻度 TR。随访 98%完整(中位随访 9 年,四分位间距 5.1;10.9)。12 年总生存率为 71.6±7.22%,以非心脏死亡为竞争风险的心脏死亡累积发生率为 16±4.1%[95%置信区间(95%CI)9.5-25.7]。12 年时,以死亡为竞争风险的 TR≥3+和 TR≥2+的累积发生率分别为 1.2±1.2%(95%CI 0.1-5.8)和 28±7.7%(95%CI 14.3-43.5)。术前左心室射血分数(风险比 0.9,95%CI 0.9-1,P=0.05)和既往心脏手术(风险比 2.7,95%CI 1-7.1,P=0.03)是单变量分析中复发性 TR≥2+的预测因素,但在多变量分析中不是。

结论

严重瓣叶脱垂或牵张的复杂形式 TR 可通过三叶草技术有效治疗,长期效果非常满意,严重 TR 复发率极低。

相似文献

1
Long-term results (up to 14 years) of the clover technique for the treatment of complex tricuspid valve regurgitation.三叶草技术治疗复杂三尖瓣反流的长期结果(最长 14 年)。
Eur J Cardiothorac Surg. 2017 Jul 1;52(1):125-130. doi: 10.1093/ejcts/ezx027.
2
The clover technique for the treatment of complex tricuspid valve insufficiency: midterm clinical and echocardiographic results in 66 patients.三叶草技术治疗复杂三尖瓣关闭不全:66 例患者的中期临床和超声心动图结果。
Eur J Cardiothorac Surg. 2010 Jun;37(6):1297-303. doi: 10.1016/j.ejcts.2009.12.020. Epub 2010 Feb 1.
3
CorMatrix Anterior Leaflet Augmentation of the Tricuspid Valve: Midterm Results.CorMatrix 三尖瓣前瓣叶增强:中期结果。
Heart Surg Forum. 2021 Mar 8;24(2):E261-E266. doi: 10.1532/hsf.3599.
4
Tricuspid Annuloplasty for Tricuspid Regurgitation Secondary to Left-Sided Heart Valve Disease: Immediate Outcomes and Risk Factors for Late Failure.三尖瓣环成形术治疗左心瓣膜病继发三尖瓣反流:近期结果和晚期失败的危险因素。
Can J Cardiol. 2016 Jun;32(6):760-6. doi: 10.1016/j.cjca.2015.09.007. Epub 2015 Sep 21.
5
Assessment of functional tricuspid regurgitation using 320-detector-row multislice computed tomography: risk factor analysis for recurrent regurgitation after tricuspid annuloplasty.使用 320 排多层螺旋 CT 评估功能性三尖瓣反流:三尖瓣环成形术后反流复发的危险因素分析。
J Thorac Cardiovasc Surg. 2014 Jan;147(1):312-20. doi: 10.1016/j.jtcvs.2012.11.017. Epub 2012 Dec 13.
6
Mitral Valve Repair Without Repair of Moderate Tricuspid Regurgitation.二尖瓣修复而不修复中度三尖瓣反流
Ann Thorac Surg. 2015 Dec;100(6):2206-12. doi: 10.1016/j.athoracsur.2015.05.108. Epub 2015 Aug 29.
7
Long-term outcomes of tricuspid annuloplasty for functional tricuspid regurgitation associated with degenerative mitral regurgitation: suture annuloplasty versus ring annuloplasty using a flexible band.退行性二尖瓣反流相关功能性三尖瓣反流的三尖瓣环成形术的长期结果:缝线环成形术与使用柔性带的环环成形术对比
Ann Thorac Cardiovasc Surg. 2014;20(6):1026-33. doi: 10.5761/atcs.oa.13-00292. Epub 2014 Feb 28.
8
Surgical management of functional tricuspid regurgitation with a new remodeling annuloplasty ring.采用新型重塑瓣环成形环对功能性三尖瓣反流进行手术治疗。
Mt Sinai J Med. 2006 Oct;73(6):874-9.
9
Long-Term Outcomes After Mitral Valve Replacement and Tricuspid Annuloplasty in Rheumatic Patients.风湿性心脏病患者二尖瓣置换和三尖瓣环成形术后的长期结果。
Ann Thorac Surg. 2019 Feb;107(2):539-545. doi: 10.1016/j.athoracsur.2018.09.012. Epub 2018 Oct 25.
10
Adding tricuspid repair to standard open heart surgery does not increase risk but improves right ventricular function.在标准心脏直视手术中增加三尖瓣修复术不会增加风险,但能改善右心室功能。
Interact Cardiovasc Thorac Surg. 2019 Sep 1;29(3):416-421. doi: 10.1093/icvts/ivz106.

引用本文的文献

1
TriClover: Novel Transcatheter Technique to Repair the Tricuspid Valve With High Effectiveness and Wide Indications.TriClover:用于修复三尖瓣的新型经导管技术,具有高效性和广泛适应症。
JACC Basic Transl Sci. 2024 Oct 28;9(12):1382-1384. doi: 10.1016/j.jacbts.2024.10.003. eCollection 2024 Dec.
2
Tricuspid Valve Regurgitation: Current Understanding and Novel Treatment Options.三尖瓣反流:当前认识与新的治疗选择
J Soc Cardiovasc Angiogr Interv. 2023 Jul 5;2(5):101041. doi: 10.1016/j.jscai.2023.101041. eCollection 2023 Sep-Oct.
3
Modified Clover Technique Using Automated Suture Placement and Securing Technology in a Passive Beating Heart Model.
在被动跳动心脏模型中使用自动缝线放置和固定技术的改良三叶草技术。
Bioengineering (Basel). 2024 Jun 29;11(7):666. doi: 10.3390/bioengineering11070666.
4
A Novel Transcatheter Device for the Edge-to-Edge Treatment of Tricuspid Regurgitation: A Preliminary Evaluation.一种用于三尖瓣反流的缘对缘治疗的新型经导管装置:初步评估。
Ann Biomed Eng. 2024 Mar;52(3):556-564. doi: 10.1007/s10439-023-03399-4. Epub 2023 Nov 7.